null

PE Anti-Human CD274/PD-L1 Antibody [29E.2A3] (AGEL1649)

SKU:
AGEL1649
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Applications:
FC
$263 - $695
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

PE Anti-Human CD274/PD-L1 Antibody [29E.2A3]

The Human CD274 (PD-L1) Monoclonal Antibody (PE Conjugated, 29E.2A3) from Assay Genie (catalog number AGEL1649) is a cutting-edge tool for researchers studying the programmed death-ligand 1 (PD-L1) pathway, a critical regulator of immune responses and a key target in immunotherapy.This monoclonal antibody, derived from mouse hybridoma technology, specifically targets the CD274 protein (PD-L1) in human samples and is conjugated with phycoerythrin (PE) for easy detection and analysis. Validated for multiple applications including flow cytometry and immunofluorescence, this antibody enables precise identification and quantification of PD-L1 expression on various cell types.PD-L1, a major immune checkpoint molecule, is known to play a crucial role in immune evasion, allowing cancer cells to evade immune surveillance and enabling tumor growth.

Targeting the PD-L1 pathway has shown promising results in cancer immunotherapy, making this antibody an invaluable tool for researchers investigating PD-L1 expression in cancer biology, immunology, and drug development.By providing a high-affinity and specific binding to PD-L1, the Human CD274 Monoclonal Antibody (PE Conjugated, 29E.2A3) offers researchers a reliable means to study the mechanisms of immune checkpoint blockade in cancer and other immunological contexts, ultimately contributing to the development of novel therapeutic strategies for combatting cancer and other immune-related disorders.